Simon-Kucher & Partners’ Life Sciences European Strategy Forum 2018

Monetizing Medicines in a New Era – Innovations meet regulation
10:30 a.m. - 5:00 p.m.

Radisson Blu Hotel Zurich Airport, Flughafenstrasse, Zurich 8058 , Switzerland

OCT

11

 

Join us for Simon-Kucher & Partners’ Life Sciences European Strategy Forum in Zurich 2018, where experts from Simon-Kucher & Partners and the Life Sciences industry will present perspectives and discuss practical solutions regarding current and evolving trends within the landscape.

Staying ahead of peers means investing in new products, capabilities and innovative business models. Besides the challenge to find successful monetization approaches for new offers such as digital solutions, innovative and paradigm-shifting therapies are also causing headaches to the industry. In addition, HTA bodies increase their collaboration and we see first examples of joint price negotiations. We will discuss where this is heading, including expectations by payers and the pharmaceutical industry on potential changes, resulting challenges and solutions.

Why attend?

  • Learn and discuss current and evolving trends within the industry from our experts in the Life Sciences practice
  • Take home ideas, best practices and approaches on how to monetize innovations beyond the benefits of the actual drug
  • Network and share ideas with pricing and market access experts from inside and outside the industry

 

Please click here for further information about our Simon-Kucher & Partners’ Pricing & Market Access Academy 2018.

Agenda

10:30 - 11:00 a.m.
Registration and coffee
11:00 - 11:05 a.m.
Welcome and opening remarks
Speaker(s)
11:05 - 12:00 p.m.
Monetizing value beyond the drug: Integrated healthcare and digital solutions
Speaker(s)
12:00 - 1:15 p.m.
Panel discussion: Is the payer community ready for paradigm-shifting therapies?

Views from the payer community on the key challenges and potential solutions for successfully monetizing paradigm-shifting therapies

Discussion with Malcolm Qualie - Pharmacy Lead Specialised Commissioning NHS England, Dr. Mathias Flume, MBA, Head of drug department, KVWL as well as further payers and experts from the industry, moderated by

 

Speaker(s)
1:15 - 2:15 p.m.
Lunch
2:15 – 3:15 p.m.
Break-out session
Rethinking your go-to-market sales models:

From strategy to execution

Speaker(s)
Playing the international price referencing game right:

Smart approaches for practical implementation

3:15 – 3:30 p.m.
Coffee break
3:30 – 4:10 p.m.
HTA collaboration in the EU – the next big thing in the coming decade?

Dr. Ansgar Hebborn, Head – Global HTA & Payment Policy, F. Hoffmann-La Roche AG

4:10 – 4:50 p.m.
Panel discussion: What are the implications for the pharmaceutical industry?

Outlook and expectations by payers and the pharmaceutical industry on potential changes, resulting challenges and potential solutions

Discussion with Malcolm Qualie - Pharmacy Lead Specialised Commissioning NHS England, as well as further payers and experts from the industry, moderated by

Speaker(s)
4:50 – 5:00 p.m.
Wrap-up and outlook
Speaker(s)
5:00 p.m.
Networking and cocktail reception